Diabetes - New-wiki

Novel	Symbols	Name 1	Name 2	Pathways 1 Hide	Pathways 2 Hide	Drugs 1 Hide	Drugs 2 Hide	Diseases 1 Hide	Diseases 2 Hide
Novel Novel	Symbols USP2 and DEPDC5	Name 1 ubiquitin specific peptidase 2	Name2 DEP domain containing 5, GATOR1 subcomplex subunit	Pathway 1 TNFR1-induced proapoptotic signaling Regulation of TNFR1 signaling TNFR1-induced NF-kappa-B signaling pathway Ub-specific processing proteases Regulation of TP53 Degradation	Pathway 2 Amino acids regulate mTORC1	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols COMT and TRHR	Name 1 catechol-O-methyltransferase	Name2 thyrotropin releasing hormone receptor	Pathway 1 Methylation Enzymatic degradation of dopamine by COMT Enzymatic degradation of Dopamine by monoamine oxidase Potential therapeutics for SARS	Pathway 2 Peptide ligand-binding receptors G alpha (q) signalling events	Drugs 1 Ademetionine Tolcapone Entacapone 3,5-Dinitrocatechol 2-Methoxyestradiol BIA N-[(E)-3-[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide Nialamide (3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE 7,8-dihydroxy-4-phenyl-2H-chromen-2-one Opicapone	Drugs 2 Protirelin	Diseases 1	Diseases 2
Novel Novel	Symbols ARRB1 and CCR5	Name 1 arrestin beta 1	Name2 C-C motif chemokine receptor 5	Pathway 1 Activated NOTCH1 Transmits Signal to the Nucleus G alpha (s) signalling events Lysosome Vesicle Biogenesis Golgi Associated Vesicle Biogenesis Thrombin signalling through proteinase activated receptors (PARs) Activation of SMO Activation of SMO MAP2K and MAPK activation Ub-specific processing proteases Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Signaling downstream of RAS mutants Signaling by RAF1 mutants TGFBR3 regulates TGF-beta signaling	Pathway 2 Binding and entry of HIV virion Chemokine receptors bind chemokines G alpha (i) signalling events Interleukin-10 signaling	Drugs 1	Drugs 2 Maraviroc AMD-070 CCR5 mAb Leronlimab Aplaviroc Vicriviroc Ibalizumab INCB-9471	Diseases 1	Diseases 2
Novel Novel	Symbols FAM107A and RNLS	Name 1 family with sequence similarity 107 member A	Name2 renalase, FAD dependent amine oxidase	Pathway 1	Pathway 2 Nicotinate metabolism	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols PPP2CA and NXN	Name 1 protein phosphatase 2 catalytic subunit alpha	Name2 nucleoredoxin	Pathway 1 Inhibition of replication initiation of damaged DNA by RB1/E2F1 Spry regulation of FGF signaling Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal PP2A-mediated dephosphorylation of key metabolic factors DARPP-32 events Degradation of beta-catenin by the destruction complex Beta-catenin phosphorylation cascade ERK/MAPK targets ERKs are inactivated MASTL Facilitates Mitotic Progression Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion Initiation of Nuclear Envelope (NE) Reformation Co-stimulation by CD28 Co-inhibition by CTLA4 Platelet sensitization by LDL Disassembly of the destruction complex and recruitment of AXIN to the membrane Disassembly of the destruction complex and recruitment of AXIN to the membrane Signaling by GSK3beta mutants CTNNB1 S33 mutants aren't phosphorylated CTNNB1 S37 mutants aren't phosphorylated CTNNB1 S45 mutants aren't phosphorylated CTNNB1 T41 mutants aren't phosphorylated APC truncation mutants have impaired AXIN binding AXIN missense mutants destabilize the destruction complex Truncations of AMER1 destabilize the destruction complex RHO GTPases Activate Formins RAF activation Negative regulation of MAPK pathway Regulation of TP53 Degradation PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Mitotic Prometaphase Cyclin D associated events in G1 Cyclin A/B1/B2 associated events during G2/M transition Regulation of glycolysis by fructose 2,6-bisphosphate metabolism EML4 and NUDC in mitotic spindle formation Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) PKR-mediated signaling Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells	Pathway 2	Drugs 1 Vitamin E 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols RAB3IL1 and SATB2	Name 1 RAB3A interacting protein like 1	Name2 SATB homeobox 2	Pathway 1 RAB GEFs exchange GTP for GDP on RABs	Pathway 2 SUMOylation of chromatin organization proteins RUNX2 regulates osteoblast differentiation	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols RAB3IL1 and TTC7B	Name 1 RAB3A interacting protein like 1	Name2 tetratricopeptide repeat domain 7B	Pathway 1 RAB GEFs exchange GTP for GDP on RABs	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols TFF1 and BTN3A1	Name 1 trefoil factor 1	Name2 butyrophilin subfamily 3 member A1	Pathway 1 Estrogen-dependent gene expression	Pathway 2 Butyrophilin (BTN) family interactions	Drugs 1 Raloxifene Afimoxifene	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols FATE1 and NRSN1	Name 1 fetal and adult testis expressed 1	Name2 neurensin 1	Pathway 1	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols APPBP2 and KIF6	Name 1 amyloid beta precursor protein binding protein 2	Name2 kinesin family member 6	Pathway 1	Pathway 2 COPI-dependent Golgi-to-ER retrograde traffic Kinesins	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols APPBP2 and DCD	Name 1 amyloid beta precursor protein binding protein 2	Name2 dermcidin	Pathway 1	Pathway 2 Antimicrobial peptides	Drugs 1	Drugs 2 Zinc Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Diseases 1	Diseases 2
Novel Novel	Symbols ACTN1 and XRCC4	Name 1 actinin alpha 1	Name2 X-ray repair cross complementing 4	Pathway 1 Platelet degranulation Syndecan interactions Nephrin family interactions Regulation of cytoskeletal remodeling and cell spreading by IPP complex components RHOD GTPase cycle RHOBTB2 GTPase cycle RHOF GTPase cycle	Pathway 2 2-LTR circle formation SUMOylation of DNA damage response and repair proteins Nonhomologous End-Joining (NHEJ)	Drugs 1 Human calcitonin Copper	Drugs 2 S-(Dimethylarsenic)Cysteine	Diseases 1	Diseases 2
Novel Novel	Symbols ACTN1 and CLIC5	Name 1 actinin alpha 1	Name2 chloride intracellular channel 5	Pathway 1 Platelet degranulation Syndecan interactions Nephrin family interactions Regulation of cytoskeletal remodeling and cell spreading by IPP complex components RHOD GTPase cycle RHOBTB2 GTPase cycle RHOF GTPase cycle	Pathway 2 Sensory processing of sound by inner hair cells of the cochlea Sensory processing of sound by outer hair cells of the cochlea	Drugs 1 Human calcitonin Copper	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols TRIM27 and TPRKB	Name 1 tripartite motif containing 27	Name2 TP53RK binding protein	Pathway 1 SUMOylation of ubiquitinylation proteins Regulation of PTEN stability and activity Suppression of apoptosis	Pathway 2 tRNA modification in the nucleus and cytosol	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols LPXN and PLEKHH2	Name 1 leupaxin	Name2 pleckstrin homology, MyTH4 and FERM domain containing H2	Pathway 1	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols PEX5 and ZFAND3	Name 1 peroxisomal biogenesis factor 5	Name2 zinc finger AN1-type containing 3	Pathway 1 Pexophagy	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Zellweger syndrome spectrum, including: Zellweger syndrome (ZS); Adrenoleukodystrophy, neonatal (NALD); Infantile Refsum disease (IRD)	Diseases 2
Novel Novel	Symbols SUMO1 and PDGFC	Name 1 small ubiquitin like modifier 1	Name2 platelet derived growth factor C	Pathway 1 SUMO is conjugated to E1 (UBA2:SAE1) SUMO is transferred from E1 to E2 (UBE2I, UBC9) SUMO is proteolytically processed SUMOylation of DNA damage response and repair proteins SUMOylation of transcription factors SUMOylation of transcription factors SUMOylation of ubiquitinylation proteins SUMOylation of transcription cofactors SUMOylation of transcription cofactors SUMOylation of SUMOylation proteins SUMOylation of intracellular receptors SUMOylation of intracellular receptors SUMOylation of chromatin organization proteins SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA replication proteins SUMOylation of DNA replication proteins SUMOylation of DNA methylation proteins SUMOylation of DNA methylation proteins SUMOylation of immune response proteins Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Formation of Incision Complex in GG-NER Regulation of IFNG signaling Negative regulation of activity of TFAP2 (AP-2) family transcription factors Negative regulation of activity of TFAP2 (AP-2) family transcription factors Postmitotic nuclear pore complex (NPC) reformation Maturation of nucleoprotein Maturation of nucleoprotein SUMOylation of nuclear envelope proteins PKR-mediated signaling Transcriptional and post-translational regulation of MITF-M expression and activity	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols AQP1 and CRTAC1	Name 1 aquaporin 1 (Colton blood group)	Name2 cartilage acidic protein 1	Pathway 1 Erythrocytes take up carbon dioxide and release oxygen Erythrocytes take up oxygen and release carbon dioxide Vasopressin regulates renal water homeostasis via Aquaporins Passive transport by Aquaporins Developmental Lineage of Pancreatic Ductal Cells	Pathway 2	Drugs 1 Acetazolamide B-nonylglucoside Mersalyl	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols AQP1 and TMEM45B	Name 1 aquaporin 1 (Colton blood group)	Name2 transmembrane protein 45B	Pathway 1 Erythrocytes take up carbon dioxide and release oxygen Erythrocytes take up oxygen and release carbon dioxide Vasopressin regulates renal water homeostasis via Aquaporins Passive transport by Aquaporins Developmental Lineage of Pancreatic Ductal Cells	Pathway 2	Drugs 1 Acetazolamide B-nonylglucoside Mersalyl	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols HOXB9 and PHTF1	Name 1 homeobox B9	Name2 putative homeodomain transcription factor 1	Pathway 1	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols USP2 and DEPDC5	Name 1 ubiquitin specific peptidase 2	Name2 DEP domain containing 5, GATOR1 subcomplex subunit	Pathway 1 TNFR1-induced proapoptotic signaling Regulation of TNFR1 signaling TNFR1-induced NF-kappa-B signaling pathway Ub-specific processing proteases Regulation of TP53 Degradation	Pathway 2 Amino acids regulate mTORC1	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols COMT and TRHR	Name 1 catechol-O-methyltransferase	Name2 thyrotropin releasing hormone receptor	Pathway 1 Methylation Enzymatic degradation of dopamine by COMT Enzymatic degradation of Dopamine by monoamine oxidase Potential therapeutics for SARS	Pathway 2 Peptide ligand-binding receptors G alpha (q) signalling events	Drugs 1 Ademetionine Tolcapone Entacapone 3,5-Dinitrocatechol 2-Methoxyestradiol BIA N-[(E)-3-[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide Nialamide (3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE 7,8-dihydroxy-4-phenyl-2H-chromen-2-one Opicapone	Drugs 2 Protirelin	Diseases 1	Diseases 2
Novel	Symbols ARRB1 and CCR5	Name 1 arrestin beta 1	Name2 C-C motif chemokine receptor 5	Pathway 1 Activated NOTCH1 Transmits Signal to the Nucleus G alpha (s) signalling events Lysosome Vesicle Biogenesis Golgi Associated Vesicle Biogenesis Thrombin signalling through proteinase activated receptors (PARs) Activation of SMO Activation of SMO MAP2K and MAPK activation Ub-specific processing proteases Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Signaling downstream of RAS mutants Signaling by RAF1 mutants TGFBR3 regulates TGF-beta signaling	Pathway 2 Binding and entry of HIV virion Chemokine receptors bind chemokines G alpha (i) signalling events Interleukin-10 signaling	Drugs 1	Drugs 2 Maraviroc AMD-070 CCR5 mAb Leronlimab Aplaviroc Vicriviroc Ibalizumab INCB-9471	Diseases 1	Diseases 2
Novel	Symbols FAM107A and RNLS	Name 1 family with sequence similarity 107 member A	Name2 renalase, FAD dependent amine oxidase	Pathway 1	Pathway 2 Nicotinate metabolism	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols PPP2CA and NXN	Name 1 protein phosphatase 2 catalytic subunit alpha	Name2 nucleoredoxin	Pathway 1 Inhibition of replication initiation of damaged DNA by RB1/E2F1 Spry regulation of FGF signaling Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal PP2A-mediated dephosphorylation of key metabolic factors DARPP-32 events Degradation of beta-catenin by the destruction complex Beta-catenin phosphorylation cascade ERK/MAPK targets ERKs are inactivated MASTL Facilitates Mitotic Progression Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion Initiation of Nuclear Envelope (NE) Reformation Co-stimulation by CD28 Co-inhibition by CTLA4 Platelet sensitization by LDL Disassembly of the destruction complex and recruitment of AXIN to the membrane Disassembly of the destruction complex and recruitment of AXIN to the membrane Signaling by GSK3beta mutants CTNNB1 S33 mutants aren't phosphorylated CTNNB1 S37 mutants aren't phosphorylated CTNNB1 S45 mutants aren't phosphorylated CTNNB1 T41 mutants aren't phosphorylated APC truncation mutants have impaired AXIN binding AXIN missense mutants destabilize the destruction complex Truncations of AMER1 destabilize the destruction complex RHO GTPases Activate Formins RAF activation Negative regulation of MAPK pathway Regulation of TP53 Degradation PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Mitotic Prometaphase Cyclin D associated events in G1 Cyclin A/B1/B2 associated events during G2/M transition Regulation of glycolysis by fructose 2,6-bisphosphate metabolism EML4 and NUDC in mitotic spindle formation Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) PKR-mediated signaling Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells	Pathway 2	Drugs 1 Vitamin E 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols RAB3IL1 and SATB2	Name 1 RAB3A interacting protein like 1	Name2 SATB homeobox 2	Pathway 1 RAB GEFs exchange GTP for GDP on RABs	Pathway 2 SUMOylation of chromatin organization proteins RUNX2 regulates osteoblast differentiation	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols RAB3IL1 and TTC7B	Name 1 RAB3A interacting protein like 1	Name2 tetratricopeptide repeat domain 7B	Pathway 1 RAB GEFs exchange GTP for GDP on RABs	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols TFF1 and BTN3A1	Name 1 trefoil factor 1	Name2 butyrophilin subfamily 3 member A1	Pathway 1 Estrogen-dependent gene expression	Pathway 2 Butyrophilin (BTN) family interactions	Drugs 1 Raloxifene Afimoxifene	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols FATE1 and NRSN1	Name 1 fetal and adult testis expressed 1	Name2 neurensin 1	Pathway 1	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols APPBP2 and KIF6	Name 1 amyloid beta precursor protein binding protein 2	Name2 kinesin family member 6	Pathway 1	Pathway 2 COPI-dependent Golgi-to-ER retrograde traffic Kinesins	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols APPBP2 and DCD	Name 1 amyloid beta precursor protein binding protein 2	Name2 dermcidin	Pathway 1	Pathway 2 Antimicrobial peptides	Drugs 1	Drugs 2 Zinc Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Diseases 1	Diseases 2
Novel	Symbols ACTN1 and XRCC4	Name 1 actinin alpha 1	Name2 X-ray repair cross complementing 4	Pathway 1 Platelet degranulation Syndecan interactions Nephrin family interactions Regulation of cytoskeletal remodeling and cell spreading by IPP complex components RHOD GTPase cycle RHOBTB2 GTPase cycle RHOF GTPase cycle	Pathway 2 2-LTR circle formation SUMOylation of DNA damage response and repair proteins Nonhomologous End-Joining (NHEJ)	Drugs 1 Human calcitonin Copper	Drugs 2 S-(Dimethylarsenic)Cysteine	Diseases 1	Diseases 2
Novel	Symbols ACTN1 and CLIC5	Name 1 actinin alpha 1	Name2 chloride intracellular channel 5	Pathway 1 Platelet degranulation Syndecan interactions Nephrin family interactions Regulation of cytoskeletal remodeling and cell spreading by IPP complex components RHOD GTPase cycle RHOBTB2 GTPase cycle RHOF GTPase cycle	Pathway 2 Sensory processing of sound by inner hair cells of the cochlea Sensory processing of sound by outer hair cells of the cochlea	Drugs 1 Human calcitonin Copper	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols TRIM27 and TPRKB	Name 1 tripartite motif containing 27	Name2 TP53RK binding protein	Pathway 1 SUMOylation of ubiquitinylation proteins Regulation of PTEN stability and activity Suppression of apoptosis	Pathway 2 tRNA modification in the nucleus and cytosol	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols LPXN and PLEKHH2	Name 1 leupaxin	Name2 pleckstrin homology, MyTH4 and FERM domain containing H2	Pathway 1	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols PEX5 and ZFAND3	Name 1 peroxisomal biogenesis factor 5	Name2 zinc finger AN1-type containing 3	Pathway 1 Pexophagy	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Zellweger syndrome spectrum, including: Zellweger syndrome (ZS); Adrenoleukodystrophy, neonatal (NALD); Infantile Refsum disease (IRD)	Diseases 2
Novel	Symbols SUMO1 and PDGFC	Name 1 small ubiquitin like modifier 1	Name2 platelet derived growth factor C	Pathway 1 SUMO is conjugated to E1 (UBA2:SAE1) SUMO is transferred from E1 to E2 (UBE2I, UBC9) SUMO is proteolytically processed SUMOylation of DNA damage response and repair proteins SUMOylation of transcription factors SUMOylation of transcription factors SUMOylation of ubiquitinylation proteins SUMOylation of transcription cofactors SUMOylation of transcription cofactors SUMOylation of SUMOylation proteins SUMOylation of intracellular receptors SUMOylation of intracellular receptors SUMOylation of chromatin organization proteins SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA replication proteins SUMOylation of DNA replication proteins SUMOylation of DNA methylation proteins SUMOylation of DNA methylation proteins SUMOylation of immune response proteins Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Formation of Incision Complex in GG-NER Regulation of IFNG signaling Negative regulation of activity of TFAP2 (AP-2) family transcription factors Negative regulation of activity of TFAP2 (AP-2) family transcription factors Postmitotic nuclear pore complex (NPC) reformation Maturation of nucleoprotein Maturation of nucleoprotein SUMOylation of nuclear envelope proteins PKR-mediated signaling Transcriptional and post-translational regulation of MITF-M expression and activity	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols AQP1 and CRTAC1	Name 1 aquaporin 1 (Colton blood group)	Name2 cartilage acidic protein 1	Pathway 1 Erythrocytes take up carbon dioxide and release oxygen Erythrocytes take up oxygen and release carbon dioxide Vasopressin regulates renal water homeostasis via Aquaporins Passive transport by Aquaporins Developmental Lineage of Pancreatic Ductal Cells	Pathway 2	Drugs 1 Acetazolamide B-nonylglucoside Mersalyl	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols AQP1 and TMEM45B	Name 1 aquaporin 1 (Colton blood group)	Name2 transmembrane protein 45B	Pathway 1 Erythrocytes take up carbon dioxide and release oxygen Erythrocytes take up oxygen and release carbon dioxide Vasopressin regulates renal water homeostasis via Aquaporins Passive transport by Aquaporins Developmental Lineage of Pancreatic Ductal Cells	Pathway 2	Drugs 1 Acetazolamide B-nonylglucoside Mersalyl	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols HOXB9 and PHTF1	Name 1 homeobox B9	Name2 putative homeodomain transcription factor 1	Pathway 1	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2

Page 43 out of 58 pages

Search Results : Diabetes